Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2026-01-01 @ 8:32 PM
Study NCT ID:
NCT04561466
Status:
COMPLETED
Last Update Posted:
2023-09-22
First Post:
2019-03-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy
Sponsor:
Hôpital Necker-Enfants Malades
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
beza16
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None